Sharda Cropchem delivered strong Q2 & H1 FY26 results. **Business Performance:** Consolidated revenue jumped 20% in Q2 to Rs. 929.1 Cr and 23% in H1 to Rs. 1,913.9 Cr.

The Agrochemical segment was the main driver, growing 27% (Q2) and 26% (H1), fueled by a massive 65% rise in insecticide sales for Q2. Europe and NAFTA regions led this growth. **Growth Drivers & Strategy:** The company prioritizes expanding its sales force and global distribution network across 80+ countries.

It continues to invest in product registrations, boasting 2,994 already and 1,068 applications pending, leveraging its asset-light model and focus on operational efficiency. **Recent Developments:** H1 FY26 saw Rs. 250 Cr. in capital expenditure. **Key Financial Metrics:** Q2 Profit After Tax (PAT) soared 75% to Rs. 74.4 Cr, while H1 PAT surged 212% to Rs. 217.2 Cr.

EBITDA saw healthy jumps of 71% (Q2) and 69% (H1). Gross margins improved to ~35%, with EPS at Rs. 8.24 (Q2) and Rs. 24.06 (H1). Working capital days were cut by 34. **Management Outlook:** Management expects stable gross margins in FY26 due to better input costs and pricing.

They see strong tailwinds from global food demand.